1Life may consider a takeover offer

Article Excerpt

We like 1Life’s outlook: we think the company will keep attracting corporations, and their employees, in this largely untapped market. That will push up returns for investors in this high-growth firm. Meantime, the chance of a takeover bid adds to the stock’s appeal. 1LIFE HEALTHCARE, $9.70, is a buy. The company (Nasdaq symbol ONEM; TSINetwork Rating: Extra Risk) (www.onemedical.com; Shares o/s: 194.0 million; Market cap: $1.9 billion; No divd.) is a membership-based provider of primary health care through its One Medical technology platform. It has attracted more than 767,000 members through over 8,000 employer clients, spread across 25 U.S. states. They access its services online but also at 182 physical locations. The stock jumped recently, after a report that the company is considering its options after getting takeover interest. 1Life is said to have drawn acquisition interest from companies including CVS Health. A potential sale comes almost a year after 1Lifeagreed agreed to acquire Iora Health for $2.1 billion. In September 2021, it then completed the…

You are trying to access subscriber-only content.

To read this article, you may subscribe or sign in.
If you are already a subscriber, log in here.

If you wish to become a subscriber, click here. Or you may enjoy access to all our publications when you become a Member of Pat McKeough's Inner Circle Pro.